C07D 491/04
Ortho-condensed systems
C07D491/04 (Ortho-condensed systems) appears on 4,956 US grants and 5,508 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,956
- Published applications
- 5,508
- Assignees
- 1,887
- Inventors
- 15,682
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 42 | 0 |
| 1977 | 42 | 0 |
| 1978 | 37 | 0 |
| 1979 | 33 | 0 |
| 1980 | 26 | 0 |
| 1981 | 41 | 0 |
| 1982 | 29 | 0 |
| 1983 | 40 | 0 |
| 1984 | 39 | 0 |
| 1985 | 37 | 0 |
| 1986 | 44 | 0 |
| 1987 | 51 | 0 |
| 1988 | 51 | 0 |
| 1989 | 55 | 0 |
| 1990 | 33 | 0 |
| 1991 | 49 | 0 |
| 1992 | 48 | 0 |
| 1993 | 54 | 0 |
| 1994 | 41 | 0 |
| 1995 | 56 | 0 |
| 1996 | 85 | 0 |
| 1997 | 86 | 0 |
| 1998 | 73 | 0 |
| 1999 | 77 | 0 |
| 2000 | 72 | 0 |
| 2001 | 95 | 32 |
| 2002 | 104 | 93 |
| 2003 | 98 | 156 |
| 2004 | 95 | 188 |
| 2005 | 68 | 167 |
| 2006 | 112 | 177 |
| 2007 | 86 | 176 |
| 2008 | 92 | 147 |
| 2009 | 95 | 175 |
| 2010 | 134 | 197 |
| 2011 | 120 | 205 |
| 2012 | 136 | 182 |
| 2013 | 181 | 207 |
| 2014 | 176 | 235 |
| 2015 | 186 | 229 |
| 2016 | 163 | 251 |
| 2017 | 198 | 216 |
| 2018 | 175 | 245 |
| 2019 | 202 | 240 |
| 2020 | 186 | 305 |
| 2021 | 186 | 224 |
| 2022 | 172 | 261 |
| 2023 | 170 | 370 |
| 2024 | 172 | 328 |
| 2025 | 202 | 289 |
| 2026 | 111 | 213 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Organic compound, light-emitting device, light-emitting apparatus, electronic appliance, and lighting device6 Oct 2026US 12,753,182 B2Semiconductor Energy Laboratory Co.Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystalline forms of a parp1 inhibitor8 Oct 2026US 2026/0308163 A1Gilead Sciences, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Brm selective degradation agent and use thereof8 Oct 2026US 2026/0308165 A1
- Oxadiazolyl dihydropyrano[2,3-b]pyridine inhibitors of hipk2 for treating kidney fibrosis8 Oct 2026US 2026/0308166 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Methods and apparatus for treating back pain197US 7,331,956 B2ArthroCare Corporation · 2008